Contact Levi & Korsinsky by April 13, 2026 Deadline to Join Class Action Against uniQure N.V.(QURE)
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of uniQure investors who were adversely affected by alleged securities fraud between
https://zlk.com/pslra-1/uniqure-lawsuit-submission-form?prid=183795&wire=4
QURE investors may also contact
CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) the design of uniQure's Pivotal Study—including comparison of the Pivotal Study results to the ENROLL-HD external historical data set—was not fully approved by the FDA; (2) defendants downplayed the likelihood that, despite purportedly highly successful results from the Pivotal Study, uniQure would have to delay its Biologics License Application ("BLA") timeline to perform additional studies to supplement its BLA submission; and (3) as a result, defendants' statements about the Company's business, operations, and prospects lacked a reasonable basis.
WHAT'S NEXT? If you suffered a loss in uniQure during the relevant time frame, you have until
NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.
WHY
CONTACT:
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/contact-levi--korsinsky-by-april-13-2026-deadline-to-join-class-action-against-uniqure-nvqure-302696598.html
SOURCE